MX2009012704A - Inhibidores de transcriptasa inversa de no nucleosidos. - Google Patents
Inhibidores de transcriptasa inversa de no nucleosidos.Info
- Publication number
- MX2009012704A MX2009012704A MX2009012704A MX2009012704A MX2009012704A MX 2009012704 A MX2009012704 A MX 2009012704A MX 2009012704 A MX2009012704 A MX 2009012704A MX 2009012704 A MX2009012704 A MX 2009012704A MX 2009012704 A MX2009012704 A MX 2009012704A
- Authority
- MX
- Mexico
- Prior art keywords
- reverse transcriptase
- treatment
- transcriptase inhibitors
- nucleoside reverse
- hiv
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a compuestos de Fórmula (I), en donde R1, X1, X2 y A, son como se definen en la presente, o sales de los mismos farmacéuticamente aceptables, inhiben la transcriptasa inversa del VIH-1 y proporcionan un medio para la prevención y tratamiento de infecciones por VIH-1 y el tratamiento de SIDA y/o ARC. La presente invención también se refiere a composiciones que contienen compuestos de fórmula (I), útiles para la prevención y tratamiento de infecciones por VIH-1 y el tratamiento de SIDA y/o ARC.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93225107P | 2007-05-30 | 2007-05-30 | |
PCT/EP2008/056165 WO2008145562A1 (en) | 2007-05-30 | 2008-05-20 | Non-nucleoside reverse transcriptase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009012704A true MX2009012704A (es) | 2009-12-08 |
Family
ID=39712538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009012704A MX2009012704A (es) | 2007-05-30 | 2008-05-20 | Inhibidores de transcriptasa inversa de no nucleosidos. |
Country Status (17)
Country | Link |
---|---|
US (1) | US8026362B2 (es) |
EP (1) | EP2155692B1 (es) |
JP (1) | JP5167350B2 (es) |
KR (1) | KR101542629B1 (es) |
CN (1) | CN101679294B (es) |
AR (1) | AR066743A1 (es) |
AU (1) | AU2008257771B2 (es) |
BR (1) | BRPI0811645A2 (es) |
CA (1) | CA2687747C (es) |
CL (1) | CL2008001537A1 (es) |
EA (1) | EA016386B1 (es) |
ES (1) | ES2542153T3 (es) |
IL (1) | IL202143A (es) |
MX (1) | MX2009012704A (es) |
PE (1) | PE20090296A1 (es) |
TW (1) | TWI425946B (es) |
WO (1) | WO2008145562A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2008001631A1 (es) * | 2007-06-06 | 2009-01-02 | Smithkline Beecham Corp | Compuestos derivados de heterociclos sustituidos, con la presencia de un grupo fenoxi, inhibidores de transcriptasa inversa; composicion farmaceutica; y uso en el tratamiento de infecciones virales por vih. |
DE102008030091B4 (de) * | 2008-06-25 | 2011-03-03 | Resprotect Gmbh | Uracilderivate und deren Verwendung |
WO2019224754A1 (en) * | 2018-05-23 | 2019-11-28 | Mor Research Applications Ltd. | Toll-like receptor 4 (tlr4) inhibitors and use thereof |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4110470A (en) * | 1965-10-07 | 1978-08-29 | Horst Kummer | Pharmaceutical composition comprising d,l-α-methyl-thyroxine ethyl ester and the salts thereof and the control of cholesterol and triglyceride blood level therewith |
US4949314A (en) | 1966-08-16 | 1990-08-14 | The United States Of America As Represented By The Secretary Of The Navy | Method and means for increasing echo-ranging-search rate |
GB1601310A (en) * | 1978-05-23 | 1981-10-28 | Lilly Industries Ltd | Aryl hydantoins |
US4518584A (en) | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
GB8327880D0 (en) | 1983-10-18 | 1983-11-16 | Ajinomoto Kk | Saccharomyces cerevisiae |
US4569790A (en) | 1984-03-28 | 1986-02-11 | Cetus Corporation | Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions |
US4530787A (en) | 1984-03-28 | 1985-07-23 | Cetus Corporation | Controlled oxidation of microbially produced cysteine-containing proteins |
US4604377A (en) | 1984-03-28 | 1986-08-05 | Cetus Corporation | Pharmaceutical compositions of microbially produced interleukin-2 |
IL76360A0 (en) | 1984-09-26 | 1986-01-31 | Takeda Chemical Industries Ltd | Mutual separation of proteins |
US4752585A (en) | 1985-12-17 | 1988-06-21 | Cetus Corporation | Oxidation-resistant muteins |
US4748234A (en) | 1985-06-26 | 1988-05-31 | Cetus Corporation | Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
AU622926B2 (en) | 1988-09-09 | 1992-04-30 | Nippon Kayaku Kabushiki Kaisha | Pyrimidine or purine cyclobutane derivatives |
US5925643A (en) | 1990-12-05 | 1999-07-20 | Emory University | Enantiomerically pure β-D-dioxolane-nucleosides |
US5489697A (en) | 1994-08-03 | 1996-02-06 | Medichem Research, Inc. | Method for the preparation of (+)-calanolide A and intermediates thereof |
IL117574A0 (en) | 1995-04-03 | 1996-07-23 | Bristol Myers Squibb Co | Processes for the preparation of cyclobutanone derivatives |
US7166730B2 (en) | 2000-01-27 | 2007-01-23 | Fine Tech Laboratories, Ltd | Process for the preparation of prostaglandin derivatives |
JO3429B1 (ar) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
TW200505441A (en) | 2003-03-24 | 2005-02-16 | Hoffmann La Roche | Non-nucleoside reverse transcriptase inhibitorsⅠ |
BRPI0408704A (pt) * | 2003-03-24 | 2006-03-07 | Hoffmann La Roche | benzil-piridazinonas como inibidores de transcriptase reversa |
JP4107658B2 (ja) | 2003-07-23 | 2008-06-25 | インターナショナル・ビジネス・マシーンズ・コーポレーション | 分類因子検出装置、分類因子検出方法、プログラム、及び記録媒体 |
EP1721165B1 (en) | 2004-02-27 | 2010-03-03 | Institut Curie | New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis |
JP4627315B2 (ja) | 2004-03-23 | 2011-02-09 | エフ.ホフマン−ラ ロシュ アーゲー | 非ヌクレオシド逆転写酵素阻害剤としてのベンジルピリダジノン誘導体 |
WO2005100323A1 (en) | 2004-04-15 | 2005-10-27 | F. Hoffmann-La Roche Ag | Process for preparing pyridazinone compounds |
US7166738B2 (en) | 2004-04-23 | 2007-01-23 | Roche Palo Alto Llc | Non-nucleoside reverse transcriptase inhibitors |
US7625949B2 (en) | 2004-04-23 | 2009-12-01 | Roche Palo Alto Llc | Methods for treating retroviral infections |
CA2471006A1 (en) * | 2004-06-23 | 2005-12-23 | Bayer Inc. | Silica reinforced elastomer compounds prepared with dry liquid modifiers |
EP1773790B1 (en) | 2004-07-27 | 2012-08-15 | F.Hoffmann-La Roche Ag | Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors |
WO2006026356A2 (en) | 2004-08-25 | 2006-03-09 | Ardea Biosciences, Inc. | S-TRIAZOLYL α-MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE |
ATE479693T1 (de) | 2004-09-17 | 2010-09-15 | Idenix Pharmaceuticals Inc | Phosphoindole als hiv-inhibitoren |
EP1797062B8 (en) | 2004-09-30 | 2011-05-25 | Boehringer Ingelheim International GmbH | Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors |
JP4423166B2 (ja) | 2004-10-29 | 2010-03-03 | 富士通株式会社 | 電子部品の超音波実装方法および超音波実装装置 |
WO2006067587A2 (en) | 2004-12-22 | 2006-06-29 | Pfizer Limited | Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
EP1863777A1 (en) | 2005-03-24 | 2007-12-12 | F.Hoffmann-La Roche Ag | 1,2,4 -triazole-5-one compounds as heterocyclic reverse transcriptase inhibitors |
US20060225874A1 (en) | 2005-04-11 | 2006-10-12 | Shives Gary D | Sandwiched thermal article |
AR057455A1 (es) | 2005-07-22 | 2007-12-05 | Merck & Co Inc | Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica |
WO2007039463A1 (en) | 2005-09-30 | 2007-04-12 | F. Hoffmann-La Roche Ag | Nnrt inhibitors |
RU2008119412A (ru) | 2005-10-19 | 2009-11-27 | Ф.Хоффманн-Ля Рош Аг (Ch) | N-фенил-фенилацетамидные ненуклеозидные ингибиторы обратной транскриптазы |
CN101291905A (zh) | 2005-10-19 | 2008-10-22 | 弗·哈夫曼-拉罗切有限公司 | 苯乙酰胺nnrt抑制剂 |
KR20100039348A (ko) * | 2007-06-22 | 2010-04-15 | 에프. 호프만-라 로슈 아게 | 비-뉴클레오사이드 역 전사효소 억제제로서 우레아 및 카바메이트 유도체 |
-
2008
- 2008-05-20 KR KR1020097027313A patent/KR101542629B1/ko not_active IP Right Cessation
- 2008-05-20 EA EA200901599A patent/EA016386B1/ru not_active IP Right Cessation
- 2008-05-20 EP EP08759780.3A patent/EP2155692B1/en not_active Not-in-force
- 2008-05-20 CN CN2008800179226A patent/CN101679294B/zh not_active Expired - Fee Related
- 2008-05-20 AU AU2008257771A patent/AU2008257771B2/en not_active Ceased
- 2008-05-20 CA CA2687747A patent/CA2687747C/en not_active Expired - Fee Related
- 2008-05-20 JP JP2010509787A patent/JP5167350B2/ja not_active Expired - Fee Related
- 2008-05-20 WO PCT/EP2008/056165 patent/WO2008145562A1/en active Application Filing
- 2008-05-20 ES ES08759780.3T patent/ES2542153T3/es active Active
- 2008-05-20 BR BRPI0811645-8A2A patent/BRPI0811645A2/pt not_active IP Right Cessation
- 2008-05-20 MX MX2009012704A patent/MX2009012704A/es active IP Right Grant
- 2008-05-27 PE PE2008000903A patent/PE20090296A1/es not_active Application Discontinuation
- 2008-05-28 CL CL2008001537A patent/CL2008001537A1/es unknown
- 2008-05-28 AR ARP080102236A patent/AR066743A1/es unknown
- 2008-05-29 TW TW097119955A patent/TWI425946B/zh not_active IP Right Cessation
- 2008-05-30 US US12/156,228 patent/US8026362B2/en not_active Expired - Fee Related
-
2009
- 2009-11-15 IL IL202143A patent/IL202143A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101679294B (zh) | 2012-08-08 |
IL202143A (en) | 2014-06-30 |
CA2687747A1 (en) | 2008-12-04 |
KR101542629B1 (ko) | 2015-08-06 |
CL2008001537A1 (es) | 2008-12-05 |
US8026362B2 (en) | 2011-09-27 |
WO2008145562A1 (en) | 2008-12-04 |
JP2010528083A (ja) | 2010-08-19 |
EP2155692A1 (en) | 2010-02-24 |
JP5167350B2 (ja) | 2013-03-21 |
KR20100028584A (ko) | 2010-03-12 |
ES2542153T3 (es) | 2015-07-31 |
CN101679294A (zh) | 2010-03-24 |
PE20090296A1 (es) | 2009-03-27 |
TW200911260A (en) | 2009-03-16 |
BRPI0811645A2 (pt) | 2014-11-11 |
IL202143A0 (en) | 2010-06-16 |
AU2008257771A1 (en) | 2008-12-04 |
EA016386B1 (ru) | 2012-04-30 |
TWI425946B (zh) | 2014-02-11 |
US20090076045A1 (en) | 2009-03-19 |
EA200901599A1 (ru) | 2010-06-30 |
AR066743A1 (es) | 2009-09-09 |
EP2155692B1 (en) | 2015-06-17 |
CA2687747C (en) | 2015-11-17 |
AU2008257771B2 (en) | 2015-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009009920A (es) | Inhibidores no nucleosidos de transcriptasa inversa. | |
MX2010006397A (es) | Compuestos heterociclicos antivirales. | |
GEP20115320B (en) | Non-nucleoside reverse transcriptase inhibitors | |
PH12017501429A1 (en) | Derivatives of betulin | |
JOP20210301A1 (ar) | بيرولات ثلاثية الحلقة مكثفة كمُعدِّلات مضاد تريبسين ألفا-1 | |
MX2009005881A (es) | Derivados de 2-(piperidin-4-il)-4-fenoxi o fenilamino-pirimidina como inhibidores de la transcriptasa inversa no nucleosida. | |
MX2009012168A (es) | Derivados de pirrolopiridina y su uso como inhibidores de la enzima que escinde la proteina precursora de amiloide por el sitio beta. | |
TN2015000121A1 (en) | Gdf-8 inhibitors | |
TW200603783A (en) | Non-nucleoside reverse transcriptase inhibitors | |
UA95955C2 (ru) | Ингибиторы обратной транскриптазы вич | |
UA105911C2 (uk) | Сульфонамідні похідні | |
MX2011013771A (es) | Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17. | |
GEP20156368B (en) | Non-nucleoside reverse transcriptase inhibitors | |
GEP20186838B (en) | 5-phenoxy-3h-pyrimidin-4-one derivatives and their usage as hiv reverse transcriptase inhibitors | |
MY147390A (en) | Substituted isoindoles as bace inhibitors and their use | |
WO2009146555A8 (en) | Hiv integrase inhibitors from pyridoxine | |
MX2012010918A (es) | Analogos para el tratamiento o prevencion de infecciones por flavivirus. | |
MX2009012847A (es) | Analogos dipeptidicos como inhibidores de factores de coagulacion. | |
MX2009013804A (es) | Inhibidores novedosos de transcriptasa inversa de vih. | |
PH12019501198A1 (en) | Tetracyclic heterocycle compounds useful as hiv integrase inhibitors | |
JO3067B1 (ar) | بيرميدينات بيرازولو امينو كمثبطات ل fak | |
MX2012006805A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa. | |
MX2020011317A (es) | Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa de vih. | |
TW200716571A (en) | Heterocyclic reverse transcriptase inhibitors | |
MX2009010932A (es) | Inhibidores no nucleosidos de transcriptasa inversa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |